Association between dietary intake of flavonoids and hyperuricemia: a cross-sectional study | BMC Public Health

  • Dalbeth N, Gosling AL, Gaffo A, Abhishek A: Gout. Lancet. 2021, 397(10287):1843–1855.

  • Johnson RJ, Rideout BA: Uric Acid and Diet — Insights into the Epidemic of Cardiovascular Disease. New Engl J Med 2004, 2004 Mar 11;350(11).

  • Li C, Hsieh MC, Chang SJ. Metabolic syndrome, diabetes, and hyperuricemia. Curr Opin Rheumatol. 2013;25(2):210–6.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Ruilope LM. Antihypertensives in people with gout or asymptomatic hyperuricaemia. BMJ. 2012;344: d7961.

    Article 
    PubMed 

    Google Scholar 

  • Badve SV, Brown F, Hawley CM, Johnson DW, Kanellis J, Rangan GK, Perkovic V. Challenges of conducting a trial of uric-acid-lowering therapy in CKD. Nat Rev Nephrol. 2011;7(5):295–300.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Han T, Meng X, Shan R, Zi T, Li Y, Ma H, Zhao Y, Shi D, Qu R, Guo X, et al. Temporal relationship between hyperuricemia and obesity, and its association with future risk of type 2 diabetes. Int J Obes (Lond). 2018;42(7):1336–44.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Zhu Y, Pandya BJ, Choi HK: Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007–2008. Am J Med 2012, 125(7):679–687 e671.

  • Liu H, Zhang XM, Wang YL, Liu BC. Prevalence of hyperuricemia among Chinese adults: a national cross-sectional survey using multistage, stratified sampling. J Nephrol. 2014;27(6):653–8.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Chen-Xu M, Yokose C, Rai SK, Pillinger MH, Choi HK. Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007–2016. Arthritis Rheumatol. 2019;71(6):991–9.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Uaratanawong S, Suraamornkul S, Angkeaw S, Uaratanawong R. Prevalence of hyperuricemia in Bangkok population. Clin Rheumatol. 2011;30(7):887–93.

    Article 
    PubMed 

    Google Scholar 

  • Nagahama K, Iseki K, Inoue T, Touma T, Ikemiya Y. TAKISHITA S: Hyperuricemia and Cardiovascular Risk Factor Clustering in a Screened Cohort in Okinawa, Japan. Hypertens Res. 2004;27(4):2004.

    Article 

    Google Scholar 

  • Spencer JP: Flavonoids: modulators of brain function? Br J Nutr 2008, 99 E Suppl 1:ES60–77.

  • Yi YS. Regulatory roles of flavonoids on inflammasome activation during inflammatory responses. Mol Nutr Food Res. 2018;62(13): e1800147.

    Article 
    PubMed 

    Google Scholar 

  • Kopustinskiene DM, Jakstas V, Savickas A, Bernatoniene J: Flavonoids as Anticancer Agents. Nutrients 2020, 12(2).

  • Liang G, Nie Y, Chang Y, Zeng S, Liang C, Zheng X, Xiao D, Zhan S, Zheng Q. Protective effects of Rhizoma smilacis glabrae extracts on potassium oxonate- and monosodium urate-induced hyperuricemia and gout in mice. Phytomedicine. 2019;59: 152772.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Chen Y, Zhao Z, Li Y, Yang Y, Li L, Jiang Y, Lin C, Cao Y, Zhou P, Tian Y, et al. Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase. Phytomedicine. 2021;80: 153374.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Ouyang X, Li NZ, Guo MX, Zhang MM, Cheng J, Yi LT, Zhu JX. Active Flavonoids From Lagotis brachystachya Attenuate Monosodium Urate-Induced Gouty Arthritis via Inhibiting TLR4/MyD88/NF-kappaB Pathway and NLRP3 Expression. Front Pharmacol. 2021;12: 760331.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Cui D, Liu S, Tang M, Lu Y, Zhao M, Mao R, Wang C, Yuan Y, Li L, Chen Y, et al. Phloretin ameliorates hyperuricemia-induced chronic renal dysfunction through inhibiting NLRP3 inflammasome and uric acid reabsorption. Phytomedicine. 2020;66: 153111.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Daniel I. Feig MD, Ph.D., Duk-Hee Kang MD, Richard J. Johnson MD: Uric Acid and Cardiovascular Risk. New Engl J Med 2008, 2008;359:1811–21.

  • Ali MK, Bullard KM, Beckles GL, Stevens MR, Barker L, Narayan KM, Imperatore G: Household income and cardiovascular disease risks in U.S. children and young adults: analyses from NHANES 1999–2008. Diabetes Care 2011, 34(9):1998–2004.

  • Rattan P, Penrice DD, Ahn JC, Ferrer A, Patnaik M, Shah VH, Kamath PS, Mangaonkar AA, Simonetto DA. Inverse association of telomere length with liver disease and mortality in the US population. Hepatol Commun. 2022;6(2):399–410.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Wang K, Zhao Y, Nie J, Xu H, Yu C, Wang S: Higher HEI-2015 Score Is Associated with Reduced Risk of Depression: Result from NHANES 2005–2016. Nutrients 2021, 13(2).

  • Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, (2002) 106:3143–421.

  • Levey S. Schmid, Zhang, III C: a new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;2009(150):604–12.

    Article 

    Google Scholar 

  • Choi HK, McCormick N, Lu N, Rai SK, Yokose C, Zhang Y. Population impact attributable to modifiable risk factors for hyperuricemia. Arthritis Rheumatol. 2020;72(1):157–65.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Hwa KS, Chung DM, Chung YC, Chun HK. Hypouricemic effects of anthocyanin extracts of purple sweet potato on potassium oxonate-induced hyperuricemia in mice. Phytother Res. 2011;25(9):1415–7.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Lodhi S, Vadnere GP, Patil KD, Patil TP. Protective effects of luteolin on injury induced inflammation through reduction of tissue uric acid and pro-inflammatory cytokines in rats. J Tradit Complement Med. 2020;10(1):60–9.

    Article 
    PubMed 

    Google Scholar 

  • Li Y, Zhao Z, Luo J, Jiang Y, Li L, Chen Y, Zhang L, Huang Q, Cao Y, Zhou P, et al. Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/beta-catenin pathway. Phytomedicine. 2021;87: 153585.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Bai W, Wang C, Ren C. Intakes of total and individual flavonoids by US adults. Int J Food Sci Nutr. 2014;65(1):9–20.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Zamora-Ros R, Agudo A, Lujan-Barroso L, Romieu I, Ferrari P, Knaze V, Bueno-de-Mesquita HB, Leenders M, Travis RC, Navarro C, et al. Dietary flavonoid and lignan intake and gastric adenocarcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr. 2012;96(6):1398–408.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Kim K, Vance TM, Chun OK. Estimated intake and major food sources of flavonoids among US adults: changes between 1999–2002 and 2007–2010 in NHANES. Eur J Nutr. 2016;55(2):833–43.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, Pillinger MH, Merill J, Lee S, Prakash S et al: 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) 2012, 64(10):1431–1446.

  • Jakse B, Jakse B, Pajek M, Pajek J: Uric Acid and Plant-Based Nutrition. Nutrients 2019, 11(8).

  • Hafez RM, Abdel-Rahman TM, Naguib RM. Uric acid in plants and microorganisms: Biological applications and genetics – A review. J Adv Res. 2017;8(5):475–86.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Ye C, Huang X, Wang R, Halimulati M, Aihemaitijiang S, Zhang Z: Dietary Inflammatory Index and the Risk of Hyperuricemia: A Cross-Sectional Study in Chinese Adult Residents. Nutrients 2021, 13(12).

  • Yang Y, Zhang JL, Zhou Q. Targets and mechanisms of dietary anthocyanins to combat hyperglycemia and hyperuricemia: a comprehensive review. Crit Rev Food Sci Nutr. 2022;62(4):1119–43.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Isaka Y, Takabatake Y, Takahashi A, Saitoh T, Yoshimori T. Hyperuricemia-induced inflammasome and kidney diseases. Nephrol Dial Transplant. 2016;31(6):890–6.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Wen L, Yang H, Ma L, Fu P. The roles of NLRP3 inflammasome-mediated signaling pathways in hyperuricemic nephropathy. Mol Cell Biochem. 2021;476(3):1377–86.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Source link